Function of estrogen receptors in breast cancer

Breast Cancer

Volumn 4, Issue 4, 1997, Pages 204-208

  Parker, Malcolm G ^a   Cowley, Shaun M ^a   Heery, David ^a   Henttu, Pirkko ^a   Kalkhoven, Eric ^a   Sjöberg, Maria ^a   Valentine, Janet E ^a   White, Roger ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34250196589     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02966506     Document Type: Conference Paper

References (25)

1. Beato M, Herrlich P, Schutz G: Steroid-hormone receptors-many actors in search of a plot. Cell 83:851-857, 1995. (Pubitemid 26006527)
2. Parker MG, White R: Nuclear receptors spring into action. Nature Structural Biology 3:113-115, 1996. (Pubitemid 26044996)
3. Ignar-Trowbridge DM, Nelson KG, Bidwell MC, et al: Coupling of dual signaling pathways; Epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 89:4658-4662, 1992.
4. Bunone G, Briand P-A, Miksicek RJ, et al: Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15:2174-2183, 1996. (Pubitemid 26141134)
5. Webb P, Lopez GN, Uht RM, et al: Tamoxifen activation of the estrogen receptor/AP-1 pathway; Potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endo 9:443-456, 1995.
6. Stein B, Yang MX: Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-k and C/EBPb. Mol Cell Biol 15:4971-4979, 1995.
7. Parker MG: Steroid and related receptors. Curt Opin Cell Biol 5:499-504, 1993.
8. Kato S, Endoh H, Masuhiro Y, et al: Activation of the estrogen-receptor through phosphorylation by mitogen-activated protein-kinase. Science 270:1491-1494, 1995.
9. Danielian PS, White R, Lees JA, et al: Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11:1025-1033, 1992.
10. Henttu PMA, Kalkhoven E, Parker MG: AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol Cell Biol 17:1832-1839, 1997. (Pubitemid 27133268)
11. Onate SA, Tsai SY, Tsai M-J, et al: Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357, 1995.
12. vom Baur E, Zechel C, Heery D, et al: Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J 15: 110-124, 1996. (Pubitemid 26020394)
13. Kamei Y, Xu L, Heinzel T, et al: A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414, 1996. (Pubitemid 26160711)
14. Hanstein B, Eckner R, DiRenzo J, et al: p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci USA 93:11540-11545, 1996. (Pubitemid 26347157)
15. Jordan VC: Biochemical pharmacology of antiestrogen action. Pharmacol Rev 36:245-276, 1984. (Pubitemid 15189558)
16. Bowler J, Lilley TJ, Pittam JD, et al: Novel steroidal pure antiestrogens. Steroids 54:71-99, 1989. (Pubitemid 19242474)
17. Cavaills V, Dauvois S, Danielian PS, et al: Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci USA 91: 10009-10013, 1994. (Pubitemid 24311938)
18. Berry M, Metzger D, Chambon P: Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO J 9:2811-2818, 1990.
19. Dauvois S, Danielian PS, White R, et al: Antiestrogen ICI 164, 384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci USA 89:4037-4041, 1992.
20. Gibson MK, Nemmers LA, Beckman Jr WC, et al: The mechanism of ICI 164, 384 antiestrogenicity involves rapid loss of estrogen receptor in uterine tissue. Endocrinology 129:2000-2010, 1991.
21. Dauvois S, White R, Parker MG: The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Science 106:1377-1388, 1993 (Pubitemid 24018422)
22. Fawell SE, White R, Hoare S, et al: Inhibition of estrogen receptor-DNA binding by the 'pure' antiestrogen ICI 164, 384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci USA 87: 6883-6887, 1990.
23. Fuqua SAW, Wolf DM: Molecular aspects of estrogen receptor variants in breast cancer. Breast Cancer Res Treat 35:233-241, 1995.
24. Fuqua SAW: Estrogen receptor mutagenesis and hormone resistance. Cancer 74:1026-1029, 1994.
25. Rea D, Parker MG: Effects of an exon-5 variant of the estrogen-receptor in mcf-7 breast-cancer cells. Cancer Res 56:1556-1563, 1996. (Pubitemid 26104019)